Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Peter R. Galle | Researchclopedia

Back to researchers

Peter R. Galle

2,426

Works

108,531

Citations

128

h-index

809

i10-index

Research Topics

Liver Disease Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis Liver Disease and Transplantation

Affiliations

National Council for Scientific and Technological Development2013–2013

Goethe University Frankfurt2017–2019

University of Southern California2025–2025

University of Bern2011–2011

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”2023–2023

Top Works

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet,Sergio Ricci,et al.

200812,841 citations

Hepatitis C virus research

Hepatitis B Virus Studies

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle,Alejandro Forner,et al.

201811,344 citations

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn,Shukui Qin,et al.

20206,928 citations

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

María Reig,Alejandro Forner,et al.

20213,961 citations

Simplified criteria for the diagnosis of autoimmune hepatitis†

Elke Hennes,Mikio Zeniya,et al.

20081,851 citations

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu,Yoon‐Koo Kang,et al.

20191,632 citations

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater,Peter R. Galle,et al.

20141,526 citations

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Ann‐Lii Cheng,Shukui Qin,et al.

20211,519 citations

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa,George Lau,et al.

20221,338 citations